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ABSTRACT 
Biotechnology-based pharmaceutical products as an essential portion of the marketed 
therapeutic agents are continuously evolving due to the increased number of approved products 
as well as products entering clinical trials. Biotechnology involves the use of a living organism 
or their products for human use including medical purposes. Production of therapeutic agents 
through biotechnology is a complex multistep process that requires careful considerations in 
various aspects. Therefore it is essential to understand the differences between biotechnology-
based drugs and conventional drugs. Currently, different classes of therapeutic agents are 
produced via biotechnology, such as antibiotics, enzymes, vaccines, and monoclonal 
antibodies. In this chapter, the general production process of biotechnology-based 
pharmaceutical products is discussed along with their pharmacokinetic properties with 
particular emphasis on the common problems associated with these products. Finally, 
biotechnology-based therapeutic approaches such as gene therapy and pharmacogenomics are 
also briefly discussed. 
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